Reply to thread

Take it easy, there are many here that have launched over a dozen drugs and the BI process isn’t an indicator of someone growing a spine. Most have high Medicaid markets with low commercial access, it’s a process with a specialty product especially with the way insupport has butchered it. When Indivior finds a way to post data through separate Medicaid/Medicare plans it will even out. Remember it’s an injection, that means small market when other options are available and easily accessible